Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras

Molecular and Cellular Biology

Volumn 18, Issue 2, 1998, Pages 896-905

  Chang, Wan Pin ^a   Ye, Yihong ^a   Clevenger, Charles V ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; DIMERIZATION; GROWTH REGULATION; IMMUNOBLOTTING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR AFFINITY; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION;

EID: 0031930298     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.2.896     Document Type: Article

References (67)

1. Ali, S., M. Edery, I. Pellegrini, L. Lesueur, J. Paly, J. Djiane, and P. A. Kelly. 1992. The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. Mol. Endocrinol. 6:1242-1248.
2. Ali, S., I. Pellegrini, and P. A. Kelly. 1991. A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J. Biol. Chem. 266:20110-20117.
3. Bazan, J. F. 1990. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87:6934-6938.
4. Bernton, E. W., M. S. Meltzer, and J. W. Holaday. 1988. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401-404.
5. Boutin, J. M., M. Edery, M. Shirota, C. Jolicoeur, L. Lesueur, S. Ali, D. Gould, J. Djiane, and P. Kelly. 1989. Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol. Endocrinol. 3:1455-1461.
6. Boutin, J. M., C. Jolicoeur, H. Okamura, J. Gagnon, M. Edery, M. Shirota, D. Banville, I. Dusanter-Fourt, J. Djiane, and P. A. Kelly. 1988. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77.
7. Campbell, G. S., L. S. Argetsinger, J. N. Ihle, P. A. Kelly, J. A. Rillema, and C. Carter-Su. 1994. Activation of Jak2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants. Proc. Natl. Acad. Sci. USA 91:5232-5236.
8. Chang, W.-P., and C. V. Clevenger. 1996. Modulation of growth factor receptor function by isoform heterodimerization. Proc. Natl. Acad. Sci. USA 93:5947-5952.
9. Clevenger, C. V., W.-P. Chang, W. Ngo, T. L. M. Pasha, K. T. Montone, and J. E. Tomaszewski. 1995. Expression of prolactin and prolactin receptor in human breast carcinoma: evidence for an autocrine/paracrine loop. Am. J. Pathol. 146:1-11.
10. fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol. 8:674-681.
11. Clevenger, C. V., W. Ngo, S. M. Luger, and A. M. Gewirtz. 1995. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J. Biol. Chem. 270:13246-13253.
12. Clevenger, C. V., and T. L. Plank. 1997. Prolactin as an autocrine/paracrine growth factor in breast tissue. J. Mammary Gland Biol. Neoplasia 2:59-68.
13. Clevenger, C. V., D. H. Russell, P. M. Appasamy, and M. B. Prystowsky. 1990. Regulation of IL2-driven T-lymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. USA 87:6460-6464.
14. Clevenger, C. V., A. L. Sillman, J. Hanley-Hyde, and M. B. Prystowsky. 1992. Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130:3216-3222.
15. Clevenger, C. V., K. Thickman, W. Ngo, W.-P. Chang, S. Takayama, and J. C. Reed. 1997. Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol. Endocrinol. 11:608-618.
16. Clevenger, C. V., T. Torigoe, and J. C. Reed. 1994. Prolactin induces rapid phosphorylation and activation of prolactin receptor associated Raf-1 kinase in a T-cell line. J. Biol. Chem. 269:5559-5565.
17. Colosi, P., K. Wong, S. R. Leong, and W. I. Wood. 1993. Mutational analysis of the intracellular domain of the human growth hormone receptor. J. Biol. Chem. 268:12617-12623.
18. Damen, J. E., H. Wakao, A. Miyajima, J. Krosl, R. K. Humphries, R. L. Cutler, and G. Krystal. 1995. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:5557-5568.
19. D'Andrea, A. D., A. Yoshimura, H. Youssoufian, L. I. Zon, J.-W. Koo, and H. F. Lodish. 1991. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1980-1987.
20. Das, R., and B. K. Vonderhaar. 1997. Prolactin as a mitogen in mammary cells. J. Mammary Gland Biol. Neoplasia 2:29-39.
21. DaSilva, L., O. M. Z. Howard, H. Rui, R. A. Kirken, and W. L. Farrar. 1994. Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J. Biol. Chem. 269:18267-18270.
22. DaSilva, L., H. Rui, R. A. Erwin, O. M. Z. Howard, R. A. Kirken, M. G. Malabarba, R. H. Hackett, A. C. Larner, and W. L. Farrar. 1996. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosinesTYR402, TYR479, TYR515, and TYR580. Mol. Cell. Endocrinol. 117:131-140.
23. Dusanter-Fourt, I., P. Gaye, L. Belair, B. Petridou, P. A. Kelly, and J. Djiane. 1991. Prolactin receptor gene expression in the rabbit: identification, characterization and tissue distribution of several prolactin receptor messenger RNAs encoding a unique precursor. Mol. Cell. Endocrinol. 77:181-192.
24. Edery, M., C. Levi-Meyrueis, J. Paly, P. A. Kelly, and J. Djiane. 1994. A limited cytoplasmic region of the prolactin receptor critical for signal transduction. Mol. Cell. Endocrinol. 102:39-14.
25. Erwin, R. A., R. A. Kirken, M. G. Malabarba, W. L. Farrar, and H. Rui. 1995. Prolactin activates ras via signaling proteins She, growth factor receptor bound 2, and son of sevenless. Endocrinology 136:3512-3517.
26. Fletcher-Chiappini, S. E., M. M. Comptom, H. A. Lavoie, E. B. Day, and R. J. Witorsch. 1993. Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects. Proc. Soc. Exp. Biol. Med. 202:345-352.
27. Fukunaga, R., E. Ishizaka-Ikeda, C.-X. Pan, Y. Seto, and S. Nagata. 1991. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 10:2855-2865.
28. Gobert, S., S. Chretien, F. Gouilleux, O. Muller, C. Pallard, I. Dusanter-Fourt, B. Groner, C. LaCombe, S. Gisselbrecht, and P. Mayeux. 1996. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 15:2434-2441.
29. c chain. J. Biol. Chem. 270:21729-21737.
30. Goldsmith, M. A., W. Xu, C. Amaral, E. S. Kuczek, and W. C. Greene. 1994. The cytoplasmic domain of the interleukin-2 receptor β chain contains both unique and functionally redundant signal transduction elements. J. Biol. Chem. 269:14698-14704.
31. Goupille, O., N. Daniel, C. Bignon, J. Jolivet, and J. Djiane. 1997. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation. Mol. Endocrinol. 127:155-169.
32. Hackett, R. H., Y.-D. Wang, and A. C. Larner. 1995. Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of Jak2 and Stat proteins. J. Biol. Chem. 270:21326-21330.
33. Hansen, L. H., X. Wang, J. J. Kopchick, P. Bouchelouche, J. H. Nielsen, E. D. Galsgaard, and N. Billestrup. 1996. Identification of tyrosine residues in the intracellular domain of the growth hormone receptor required for transcriptional signaling and Stat 5 activation. J. Biol. Chem. 271:12669-12673.
34. Hartmann, D. P., J. W. Holoday, and E. W. Bernton. 1989. Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 3:2194-2202.
35. Hatakeyama, M., M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, M. Miyasaka, and T. Taniguchi. 1989. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science 244:551-556.
36. He, T.-C., N. Jiang, H. Zhuang, D. E. Quelle, and D. M. Wojchowski. 1994. The extended box subdomain of the erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis of FDC-ER cells. J. Biol. Chem. 269:18291-18294.
37. Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69-74.
38. Lammers, R., E. Van Obberghen, R. Ballotti, J. Schlessinger, and A. Ullrich. 1990. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation. J. Biol. Chem. 265:16886-16890.
39. Lebrun, J.-J., S. Ali, V. Goffin, A. Ullrich, and P. A. Kelly. 1995. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. USA 92:4031-1035.
40. Lebrun, J.-J., S. Ali, A. Ullrich, and P. A. Kelly. 1995. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required hut not sufficient for signal transduction. J. Biol. Chem. 270:10664-10670.
41. Lebrun, J. J., S. Ali, L. Sofer, A. Ullrich, and P. A. Kelly. 1994. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem. 269:14021-14026.
42. Leff, M. A., D. J. Buckley, J. S. Krumenacker, J. C. Reed, T. Miyashita, and A. R. Buckley. 1996. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax, by prolactin in rat Nb2 lymphoma cells. Endocrinology 137: 5456-5462.
43. Lesueur, L., M. Edery, S. Ali, J. Paly, P. A. Kelly, and J. Djiane. 1991. Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc. Natl. Acad. Sci. USA 88:824-828.
44. Li, B.-Q., M. Subleski, N. Fusaki, T. Yamamoto, T. Copeland, G. L. Princler, H.-F. Kung, and T. Kamata. 1996. Catalytic activity of the mouse guanine nucleotide exchanger mSOS is activated by Fyn tyrosine protein kinase and the T-cell antigen receptor in T-cells. Proc. Natl. Acad. Sci. USA 93:1001-1005.
45. Liu, K., S. Y. Lai, M. A. Goldsmith, and W. C. Greene. 1995. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor β chain that is required for growth signal transduction. J. Biol. Chem. 270:22176-22181.
46. Miura, O., J. L. Cleveland, and J. N. Ihle. 1993. Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol. Cell. Biol. 13:1788-1795.
47. Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T. Taga, and T. Kishimoto. 1991. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine family. Proc. Natl. Acad. Sci. USA 88:11349-11353.
48. Muto, A., S. Watanabe, A. Miyajima, T. Yokota, and K. Arai. 1995. High affinity chimeric granulocyte-macrophage colony-stimulating factor receptor carrying the cytoplasmic domains of the β subunit but not the α subunit transduces growth promoting signals in Ba/F3 cells. Biochem. Biophys. Res. Commun. 208:368-375.
49. Nagano, M., and P. A. Kelly. 1994. Tissue distribution and regulation of rat prolactin receptor gene expression. J. Biol. Chem. 269:13337-13345.
50. Nelson, B. H., J. D. Lord, and P. D. Greenberg. 1994. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T cell proliferation. Nature 369:333-336.
51. Nicoll, C. S. 1974. Physiological actions of prolactin, p. 253-291. In E. Knobil and W. H. Sawyer (ed.), Handbook of physiology, vol. 4, part 2. American Physiological Society, Washington, D.C.
52. Ohashi, H., K. Maruyama, Y.-C. Liu, and A. Yoshimura. 1994. Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases. Proc. Natl. Acad. Sci. USA 91:158-162.
53. O'Neal, K. D., and L.-Y. Yu-Lee. 1994. Differential signal transduction of the short, Nb2, and long prolactin receptors. Activation of interferon regulatory factor-1 and cell proliferation. J. Biol. Chem. 269:26076-26082.
54. Palacios, R., and M. Steinmetz. 1985. IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727-734.
55. Pellegrini, I., J.-J. Lebrun, S. Ali, and P. A. Kelly. 1992. Expression ot prolactin and its receptor in human lymphoid cells. Mol. Endocrmol. 6:1023-1031.
56. Perrot-Applanet, M., O. Gualillo, A. Pezet, V. Vincent, M. Edery, and P. A Kelly. 1997. Dominant negative and cooperative effects ot mutant torms of prolactin receptor. Mol. Endocrinol. 11:1020-1032.
57. Qian X., W. C. Dougall, M. E. Hellman, and M. I. Greene. 1994. Kinasedeficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation. Oncogene 9:1507-1514.
58. Qian X., C. M. LeVea, J. K. Freeman, W. C. Dougall, and M. I. Greene. 1994. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-delicient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. Proc. Natl. Acad. Sci. USA 91:1500-1504.
59. Quelle, D. E., and D. M. Wojchowski. 1991. Localized cytosolic domains of the erythropoietin receptor regulate growth signaling and down-modulate responsiveness to granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 88:4801-4805.
60. c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14:4335-4341.
61. Quelle, F. W., D. Wang, T. Nosaka, W. E. Thierfelder, D. Stravopodis, Y. Weinstein, and J. N. Ihle. 1996. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol. 16:1622-1631.
62. Rui, H., J.-J. Lebrun, R. A. Kirken, P. A. Kelly, and W. L. Farrar. 1994. JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization. Endocrinology 135:1299-1306.
63. Sato, N., K. Sakamaki, N. Terada, K.-I. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 12:4181-4189.
64. Sato, N., K. Sakamaki, N. Terada, K. Arai, and A. Miyajima. 1993. Signal transduction by the high-affinity GM-CSF receptor: two distinct regions of the common beta subunit responsible for different signaling. EMBO J. 12: 4181-4189.
65. Tartare, S., R. Ballotti, R. Lammers, F. Alengrin, T. Dull, J. Schlessinger, A. Ullrich, and E. Van Obberghen. 1991. Insulin-EGF receptor chimerae mediate tyrosine transphosphorylation and serine/threonine phosphorylation of kinase-deficient EGF receptors. J. Biol. Chem. 266:9900-9906.
66. Wang, X., C. J. Darus, B. C. Xu, and J. J. Kopchick. 1996. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation. Mol. Endocrinol. 10:1249-1260.
67. Zon, L. I., J.-F. Moreau, J.-W. Koo, B. Mathey-Prevot, and A. D. D'Andrea. 1992. The erythropoietin receptor transmembrane region is necessary for activation by the Friend spleen focus-forming virus gp55 glycoprotein. Mol. Cell. Biol. 12:2949-2957.